Research output per year
Research output per year
Personal profile
Research interests
Dr. Yohance Allette's research program centers on improving health equity in multiple sclerosis care through biomarker development, AI-assisted imaging interpretation, and educational innovation. These efforts aim to support standardized, high-quality care for patients who may lack access to frequent imaging or subspecialty follow-up.
Clinical interests
Dr. Allette's clinical practice focuses on neuroimmunology, with particular emphasis on multiple sclerosis and related disorders, including neurosarcoidosis, neuromyelitis optica spectrum disorder, and MOG-associated disease. He frequently manages complex referrals involving diagnostic uncertainty, advanced disease, or fragmented prior care.
Professional information
Medical License - State of Maryland - 2021
Education/Academic qualification
Multiple Sclerosis, Advanced Fellowship, Baltimore VA Medical Center
2021 → 2023
Neurology, Residency, Indiana University School of Medicine
2017 → 2021
Anatomy and Cellular Biology, MD/PhD, Indiana University School of Medicine
2010 → 2017
Biological Science, BS, University of Maryland
2006 → 2010
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Yohance Allette is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis
Dahal, S., Allette, Y. M., Naunton, K. & Harrison, D. M., Jan 2024, In: Multiple Sclerosis and Related Disorders. 81, 105344.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance
Harrison, D. M., Allette, Y. M., Zeng, Y., Cohen, A., Dahal, S., Choi, S., Zhuo, J. & Hua, J., May 2024, In: PloS one. 19, 5 May, e0300298.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations -
Erratum: The HMGB1-RAGE axis mediates traumatic brain injury-induced pulmonary dysfunction in lung transplantation (Science Translational Medicine (2018) 10:471 (eaaw2634) DOI:10.1126/scitranslmed.3009443)
Berg, J. M., Smith, O. M., Weber, D. J., Gracon, A. S. A., Ripsch, M. S., Fisher, A. J., Cheon, B. M., Pandya, P. H., Vittal, R., Capitano, M. L., Kim, Y., Allette, Y. M., Riley, A. A., McCarthy, B. P., Territo, P. R., Hutchins, G. D., Broxmeyer, H. E., Sandusky, G. E., White, F. A. & Wilkes, D. S., Dec 12 2018, In: Science Translational Medicine. 10, 471, eaaw2634.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Bone pain induced by multiple myeloma is reduced by targeting V-ATPase and ASIC3
Hiasa, M., Okui, T., Allette, Y. M., Ripsch, M. S., Sun-Wada, G. H., Wakabayashi, H., Roodman, G. D., White, F. A. & Yoneda, T., Mar 15 2017, In: Cancer Research. 77, 6, p. 1283-1295 13 p.Research output: Contribution to journal › Article › peer-review
Open Access89 Link opens in a new tab Scopus citations -
Decoy peptide targeted to Toll-IL-1R domain inhibits LPS and TLR4-active metabolite morphine-3 glucuronide sensitization of sensory neurons
Allette, Y. M., Kim, Y., Randolph, A. L., Smith, J. A., Ripsch, M. S. & White, F. A., Dec 1 2017, In: Scientific reports. 7, 1, 3741.Research output: Contribution to journal › Article › peer-review
Open Access13 Link opens in a new tab Scopus citations